We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Equates to 34p on current exchange rate. So not near off. It’s also only 150 shares volume!
Up over 18% in Yanke land WTF
Calm down mate.
Thanks for reply Axe, at this moment I would just like to be back in the 200p range.
Yet ANOTHER axe implosion, lol!
Busterboy.0175 - Have not lost faith in the product, it just never going to get where we all originally believed it could get to, certainly not in the short to medium term (£5 - £10 area).
If you look up the Hospital COVID patients in UK presently as a guide on where SNG is for potential value, there is roughly 5 to 6000 currently in Hospital with COVID, but only around 120 of those are actually in intensive care. The standard of care now is very effective with much cheaper alternatives so our market share is now very diminished as far as it soley be useful for COVID, and certainly not in any region of being worth billions to the company as SNG is expensive and we would need a far more dangerous variant to reappear for the drug to be bought in huge numbers (This may happen of course and ruling this out). Current variants suggest that mass "buy-up" volume is just not warranted at the present time - although I do believe in the US Market we could realise Hundreds of millions of value, but not in the Billions.
For SNG now it has to be proven to be effective for a variety of illnesses and become a multi use VIRAL Medicine which is proven across a range of illnesses. So in the short to medium term means more trials and more data. There is still a long way to go before this gets fully commercialised and realises its true value.
DUNK1973 - Wrong! I stated I was jumping on the pumps and dumps making some money, still in with 153,000 shares so button your lip if you cannot stop making crap up.
I have made the money back on the original debacle and now in with just approx £35,000 punt. But yes i will pump and dump when the opportunity arises on no news just rumour - I mean who wouldn't, we are investors aren't we, not charities! Jeez. Get a grip you lot.
Instead of just sitting and waiting for something miraculous to happen try and do something about your losses.
If there no news or RNS's by the AGM finish, then this will be another pump and dump you can look back on (everything currently rising on ramping and rumour, nothing else until solid news released. Just to note also, if there is a significant rise you will see the biggest pump and dump on this in the history of the share with everyone else up to their nuts in this.
Axe is only here for pump and dumps now.
His own words quite a few times.
Hi Axe you don't sound so upbeat about this company anymore have you lost faith. I'm still hoping and praying something will come out of it.
But for me why has there been no mention from the company on the fact they are awaiting long covid data. If they was expecting something substantial surely this would of been mention after results posted or at ATS.
It could be possible I’ve missed the comments regarding long covid but I can’t recall any such mention of long covid since results released.
There have been papers published suggesting the regulation (or deregulation) of inf could be linked to PASC.
Synairgen’s SG018 trial is a randomised placebo-controlled study being conducted in approximately 20 countries enrolling a total of 610 COVID-19 patients who require supplemental oxygen. After reporting the results for the primary and key secondary endpoints of the study, enrolled patients will continue to be assessed for long-COVID-19 symptoms.
https://www.southampton.ac.uk/news/2021/01/synairgen-phase-iii-trial.page
Tight rope
No is the answer to that. Just rampers continuing to ramp. With anything and everything. The only thing we are actually waiting for is announcements of new trials and that's about it. The rest is just topics to constantly fill up this board with from investors who have no clue what a type rope we are walking with this share at the moment
Can I ask guys, don’t want to sound like I’m deramping, but why do people think Synairgen will help with long COVID? Has this ever been suggested in data or by the company?
I'll drink to that...we deserve a change in fortunes here..!!
GLA!
Here's a toast to a positive week
GLA.
Hi billy
Not seen anything on that in relation to long covid....Seen some very mixed reviews
on how effective it is...If I do see anything I will post it! ATB!
At the very least, we should get some indication this week on whether there's been any meaningful progress in getting on another platform trial, or if NIAID is putting together an alternative to Activ-2 phase 3.
Mani - what’s your thoughts on Pfizer’s antiviral drug Paxlovid in regards to long covid-19?
SNG002 - Many thanks for the informative reply.
Back then I was only 16 years of age which is why my knowledge on the data is minimal! Thanks again :)
Billy... the licensing deal broke down due to the trials inability, in 2014, to test upon the patients admission as to whether the patient had a bacterial or viral infection. The trial was controlled by AZN.
AZN then severed their tie with Synairgen before the data was deep dived and found that those who actually did have a viral infection benefitted from the treatment. Testing now, of course, is far more advanced.... so had this trial been done in 2020-22, it would've been much easier to determine the most suitable patients. Synairgen were a bit unlucky with this.... and the world was unlucky that AZN did not continue, if this drug had been on the shelves at the start of the Pandemic, there could well have been a different outcome to the millions of deaths.
billywild..... Once you have long covid all that can be done is to manage your symptoms..
It is life-changing and affects all ages... The key to this is looking at prevention... As
far as I can tell there is nothing that has been shown to prevent this condition, so IF
SNG001 shows significant results we are sitting on a gold mine..
1.7 million new covid cases in the UK last week alone..... It is critical
that treatments are stock piled before the winter.... I trust the FDA
are still very much focused on the next Covid spike/mutation and
the need to be prepared.... ! Would not rule out applying for EUA
if our Long Covid results are robust.... !!!
Very interesting thread, Long-Covid data may well be a game changer although I’m not overly confident that application is best suited for SNG001.
Why did the licensing deal breakdown in 2014?
Agreed. If long covid positive data is a partial outcome from SNGs trials then its looking v. V. rosy....indeed.